Pulmonary Thrombosis in COVID-19 Treated by Thrombolysis: A Small Case Series Using Streptokinase

Armando Caballero López; Carlos Herrera Cartaya; Elibet Chávez González; Delvis González Reinoso; Jorge Alain Caballero Font; Naivi Sánchez Vera; Mario E. Nápoles Lizano; Alexander Vázquez Roque; Alexis Morales Valdera; Tania Crombet Ramos; Julio Betancourt Cervantes

doi:10.1055/s-0040-1716872

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2021; 47(04): 431-435
DOI: 10.1055/s-0040-1716872

Letter to the Editor

Pulmonary Thrombosis in COVID-19 Treated by Thrombolysis: A Small Case Series Using Streptokinase

Armando Caballero López

¹ICU Department, Arnaldo Milián Castro University Hospital, Santa Clara, Cuba

,

Carlos Herrera Cartaya

¹ICU Department, Arnaldo Milián Castro University Hospital, Santa Clara, Cuba

,

Elibet Chávez González

²Electrophysiology Department, Cardiocenter Ernesto “Che” Guevara, Santa Clara, Cuba

,

Delvis González Reinoso

³ICU Department, Manuel “Piti” Fajardo Rivero Hospital, Santa Clara, Cuba

,

Jorge Alain Caballero Font

¹ICU Department, Arnaldo Milián Castro University Hospital, Santa Clara, Cuba

,

Naivi Sánchez Vera

⁴Clinical Laboratory, Manuel “Piti” Fajardo Rivero Hospital, Santa Clara, Cuba

,

Mario E. Nápoles Lizano

⁵Radiology Department, Cardiocenter Ernesto “Che” Guevara, Santa Clara, Cuba

,

Alexander Vázquez Roque

⁶Radiology Department, Celestino Hernández Robau University Hospital, Santa Clara, Cuba

,

Alexis Morales Valdera

⁷Internal Medicine, International Clinic of North Keys, Villa Clara, Cuba

,

Tania Crombet Ramos

⁸Clinical Immunology Division, Center for Molecular Immunology (CIM), Havana, Cuba

,

Julio Betancourt Cervantes

⁹General Surgery Department, Manuel “Piti” Fajardo Rivero Hospital, Santa Clara, Cuba

References
1 Ministerio de Salud Pública de Cuba, Revised on June 30, 2020. Accessed September 2, 2020 at: https://salud.msp.gob.cu/category/covid-19/
2 Lippi G, Sanchis-Gomar F, Henry BM. COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon. Ann Transl Med 2020; 8 (11) 693
3 Harenberg J, Favaloro E. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives. Clin Chem Lab Med 2020; 58 (07) 1029-1036
4 Klok FA, Kruip MJHA, van der Meer NJM. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191: 145-147
5 Llerena LD, Cáceres-Lóriga FM, Betancourt BY. Recombinant streptokinase: evidences from clinical use. Eur Heart J 2005; 26 (14) 1448-1449 , author reply 1449–1450
6 Bughani U, Saha A, Kuriakose A. et al. T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab. PLoS One 2017; 12 (07) e0180088
7 Betancourt BY, Marrero-Miragaya MA, Jiménez-López G. Cuban National Network of Pharmacoepidemiology. et al; Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction. BMC Clin Pharmacol 2005; 5: 5
8 Hadadi A, Mortezazadeh M, Kolahdouzan K, Alavian G. Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?. J Med Virol 2020; 92 (07) 915-918
9 Corrales O, Hernández L, Prada D. et al. CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis. Clin Rheumatol 2019; 38 (03) 955-960
10 Rivellese F, Prediletto E. ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia. Autoimmun Rev 2020; 19 (06) 102536
11 Luo W, Yu H, Gou J. et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints 2020; 2020: 2020020407
12 Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect 2020; 9 (01) 687-690
13 Zhang Y, Cao W, Xiao M. et al. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia [in Chinese]. Zhonghua Xue Ye Xue Za Zhi 2020; 41 (04) 302-307
14 Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med 2020; 14 (02) 126-135
15 Ackermann M, Verleden SE, Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383 (02) 120-128
16 Delabranche X, Helms J, Meziani F. Immunohaemostasis: a new view on haemostasis during sepsis. Ann Intensive Care 2017; 7 (01) 117
17 Maatman TK, Jalali F, Feizpour C. et al. Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019. Crit Care Med 2020; 48 (09) e783-e790
18 Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost 2020; 120 (05) 876-878
19 Thachil J, Tang N, Gando S. et al. Laboratory haemostasis monitoring in COVID-19. J Thromb Haemost 2020
20 Poor HD, Ventetuolo CE, Tolbert T. et al. COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis. Clin Transl Med 2020
21 Lu GM, Wu SY, Yeh BM, Zhang LJ. Dual-energy computed tomography in pulmonary embolism. Br J Radiol 2010; 83 (992) 707-718